UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
SCHEDULE 13G
|
||
Under the Securities Exchange Act of 1934
|
||
(Amendment No. 3)*
|
Apellis Pharmaceuticals, Inc.
|
||
(Name of Issuer)
|
Common Stock, par value $0.0001 per share
|
||
(Title of Class of Securities)
|
037530106
|
||
(CUSIP Number)
|
December 31, 2019
|
||
(Date of Event which Requires Filing of this Statement)
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Global Healthcare Master Fund, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Cayman Islands
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,247,685 shares
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
1,247,685 shares
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,247,685 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
1.67%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Global Healthcare GP, LLC
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,247,685 shares
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
1,247,685 shares
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,247,685 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
1.67%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Private Healthcare Fund I, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,366,108 shares
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
1,366,108 shares
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,366,108 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
1.82%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Private Healthcare GP, LLC
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
1,366,108 shares
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
1,366,108 shares
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
1,366,108 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
1.82%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Cormorant Asset Management, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
2,700,000 shares
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
2,700,000 shares
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,700,000 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
3.61%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
1
|
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only)
Bihua Chen
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
||
(b) [x]
|
||
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
United States
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole Voting Power
0 shares
|
|
6 Shared Voting Power
2,700,000 shares
Refer to Item 4 below.
|
||
7 Sole Dispositive Power
0 shares
|
||
8 Shared Dispositive Power
2,700,000 shares
Refer to Item 4 below.
|
||
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
2,700,000 shares
Refer to Item 4 below.
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] N/A
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
3.61%
Refer to Item 4 below.
|
|
12
|
Type of Reporting Person (See Instructions)
IN (Individual)
|
(a)
|
Name of Issuer
|
Apellis Pharmaceuticals, Inc.
|
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
Waltham, MA 02451
|
(a)
|
Name of Person Filing
|
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Private Healthcare Fund I, LP Cormorant Private Healthcare GP, LLC Cormorant Asset Management, LP Bihua Chen |
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
200 Clarendon Street, 52nd Floor
Boston, MA 02116
|
|
(c)
|
Citizenship
|
Cormorant Global Healthcare Master Fund, LP - Cayman Islands
Cormorant Global Healthcare GP, LLC - Delaware Cormorant Private Healthcare Fund I, LP - Delaware
Cormorant Private Healthcare GP, LLC - Delaware Cormorant Asset Management, LP - Delaware
Bihua Chen - United States |
|
(d)
|
Title of Class of Securities
|
Common Stock
|
|
(e)
|
CUSIP Number
|
037530106
|
Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
[ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
(b)
|
[ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c)
|
[ ]
|
Insurance Company as defined in Section 3(a)(19) of the Act
|
(d)
|
[ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e)
|
[ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
(h)
|
[ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
(j)
|
[ ]
|
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
|
(k)
|
[ ]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
Item 4. |
Ownership***
|
(a)
|
Amount Beneficially Owned***
|
|
Cormorant Global Healthcare Master Fund, LP – 1,247,685 shares
Cormorant Global Healthcare GP, LLC – 1,247,685 shares Cormorant Private Healthcare Fund I, LP – 1,366,108 shares
Cormorant Private Healthcare GP, LLC – 1,366,108 shares Cormorant Asset Management, LP – 2,700,000 shares Bihua Chen – 2,700,000 shares
|
||
(b)
|
Percent of Class
|
|
Cormorant Global Healthcare Master Fund, LP – 1.67%
Cormorant Global Healthcare GP, LLC – 1.67% Cormorant Private Healthcare Fund I, LP – 1.82%
Cormorant Private Healthcare GP, LLC – 1.82% Cormorant Asset Management, LP – 3.61% Bihua Chen – 3.61% |
||
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
sole power to vote or to direct the vote
|
|
Cormorant Global Healthcare Master Fund, LP - 0 shares Cormorant Global Healthcare GP, LLC - 0 shares Cormorant Private Healthcare Fund I, LP – 0 shares
Cormorant Private Healthcare GP, LLC – 0 shares Cormorant Asset Management, LP - 0 shares Bihua Chen - 0 shares
|
||
(ii)
|
shared power to vote or to direct the vote
|
|
Cormorant Global Healthcare Master Fund, LP – 1,247,685 shares
Cormorant Global Healthcare GP, LLC – 1,247,685 shares Cormorant Private Healthcare Fund I, LP – 1,366,108 shares
Cormorant Private Healthcare GP, LLC – 1,366,108 shares Cormorant Asset Management, LP – 2,700,000 shares Bihua Chen – 2,700,000 shares
|
||
(iii)
|
sole power to dispose or to direct the disposition of
|
|
Cormorant Global Healthcare Master Fund, LP – 0 shares Cormorant Global Healthcare GP, LLC – 0 shares Cormorant Private Healthcare Fund I, LP – 0 shares
Cormorant Private Healthcare GP, LLC – 0 shares Cormorant Asset Management, LP – 0 shares Bihua Chen – 0 shares
|
||
(iv)
|
shared power to dispose or to direct the disposition of
|
|
Cormorant Global Healthcare Master Fund, LP – 1,247,685 shares
Cormorant Global Healthcare GP, LLC – 1,247,685 shares Cormorant Private Healthcare Fund I, LP – 1,366,108 shares
Cormorant Private Healthcare GP, LLC – 1,366,108 shares Cormorant Asset Management, LP – 2,700,000 shares Bihua Chen – 2,700,000 shares
|
Item 8. |
Identification and Classification of Members of the Group
|
Item 9. |
Notice of Dissolution of Group
|
Item 10. |
Certification
|
Exhibits
|
Exhibit
|
99.1 | Joint Filing Agreement by and among the Reporting Persons, incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the Securities and Exchange Commission on February 14, 2019. |
CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP
|
|
By: Cormorant Global Healthcare GP, LLC
|
|
its General Partner
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
CORMORANT GLOBAL HEALTHCARE GP, LLC
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
CORMORANT PRIVATE HEALTHCARE FUND I, LP
|
|
By: Cormorant Global Healthcare GP, LLC
|
|
its General Partner
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
CORMORANT PRIVATE HEALTHCARE GP, LLC
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
CORMORANT ASSET MANAGEMENT, LP
|
|
By: Cormorant Asset Management GP, LLC
|
|
its General Partner
|
|
By: /s/ Bihua Chen
|
|
Bihua Chen, Managing Member
|
|
/s/ Bihua Chen
|
|
Bihua Chen
|